United States· US:60986-2040_483ad8b7-56c6-1dc3-e063-6394a90abb23
AB
A medicinal product containing aconitum napellus; bryonia cretica subsp. dioica root, registered in United States by MARCO PHARMA INTERNATIONAL LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ACONITUM NAPELLUS; BRYONIA CRETICA SUBSP. DIOICA ROOT
- Manufacturer
- MARCO PHARMA INTERNATIONAL LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1160986-2040-3
- ndc11609862040350 mL in 1 BOTTLE (60986-2040-3)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af282f11-965f-4d6f-8ec0-d6249c7ca943 GET /v1/drugs/af282f11-965f-4d6f-8ec0-d6249c7ca943?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "3; 3",
"substance": "ACONITUM NAPELLUS; BRYONIA CRETICA SUBSP. DIOICA ROOT",
"productndc": "60986-2040",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "[hp_X]/100mL; [hp_X]/100mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about aconitum napellus; bryonia cretica subsp. dioica root.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.